NCT06420492View on ClinicalTrials.gov

Study of Novel Therapeutics for Acute Remedy of Colitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

June 1, 2027

Conditions
Ulcerative ColitisUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
Interventions
DRUG

BRS201

Groups 1, 2, 3, and 4 will all contain 5 subjects each, with each subject receiving active study drug for four weeks.

Trial Locations (2)

02467

NOT_YET_RECRUITING

Brigham and Women's Hospital, Chestnut Hill

RECRUITING

Brigham and Women's Hospital, Chestnut Hill

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER